英国一家三级重症监护病房中，严重 COVID-19 患者的影像学证实的血栓栓塞事件。
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
机构信息
Haemostasis and Thrombosis Centre, St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, United Kingdom.
NHS Blood and Transplant, Statistics and Clinical Studies, Bristol BS34 9QH, United Kingdom.
出版信息
Thromb Res. 2020 Sep;193:1-4. doi: 10.1016/j.thromres.2020.05.049. Epub 2020 May 29.
Abstract
• Venous thrombosis is common in patients with severe COVID-19 pneumonia. • Many of these thromboses may be immunothromboses due to local inflammation, rather than thromboembolic disease. • Anticoagulated patients with COVID-19 pneumonia have a risk of major bleeding.
摘要
• 重症 COVID-19 肺炎患者中常见静脉血栓形成。• 这些血栓中有许多可能是由于局部炎症引起的免疫性血栓，而不是血栓栓塞性疾病。• COVID-19 肺炎合并抗凝治疗患者有发生大出血的风险。
相似文献
1
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.英国一家三级重症监护病房中，严重 COVID-19 患者的影像学证实的血栓栓塞事件。
Thromb Res. 2020 Sep;193:1-4. doi: 10.1016/j.thromres.2020.05.049. Epub 2020 May 29.
2
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.需要体外膜肺氧合的COVID-19患者的血栓形成与凝血障碍
ASAIO J. 2020 Aug;66(8):844-846. doi: 10.1097/MAT.0000000000001208.
3
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?体外膜肺氧合用于治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征的重症患者：值得一试吗？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):460-463. doi: 10.1164/rccm.202004-1370LE.
4
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
5
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?新冠病毒肺炎：为重症患者的血栓预防开启新范式？
Crit Care. 2020 Jun 11;24(1):332. doi: 10.1186/s13054-020-03052-9.
6
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
7
Thromboembolic events in patients with SARS-CoV-2.感染新型冠状病毒2型（SARS-CoV-2）患者的血栓栓塞事件
J Vasc Surg. 2020 Aug;72(2):760-761. doi: 10.1016/j.jvs.2020.04.488. Epub 2020 Apr 30.
8
Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis.尽管采取了预防措施，但新冠病毒疾病（COVID-19）低风险患者仍出现动脉血栓栓塞并发症。
Br J Haematol. 2020 Jul;190(1):e11-e13. doi: 10.1111/bjh.16792. Epub 2020 May 28.
9
Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.基于 CT 扫描的静脉-静脉体外膜肺氧合治疗严重急性呼吸综合征冠状病毒 2 后静脉血栓栓塞事件。
Crit Care Med. 2020 Oct;48(10):e971-e975. doi: 10.1097/CCM.0000000000004504.
10
Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism.计算机断层扫描特征及 COVID-19 肺炎合并静脉血栓栓塞症的结局评估。
PLoS One. 2020 Nov 19;15(11):e0242475. doi: 10.1371/journal.pone.0242475. eCollection 2020.
引用本文的文献
1
Arterial Thrombosis in Acute Respiratory Infections: An Underestimated but Clinically Relevant Problem.急性呼吸道感染中的动脉血栓形成：一个被低估但具有临床相关性的问题。
J Clin Med. 2024 Oct 9;13(19):6007. doi: 10.3390/jcm13196007.
2
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后：系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
3
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression.探索COVID-19报告的静脉血栓栓塞风险的异质性并与其他病毒性肺炎进行比较：一项系统综述和Meta回归分析
Res Pract Thromb Haemost. 2023 Jul 13;7(5):102146. doi: 10.1016/j.rpth.2023.102146. eCollection 2023 Jul.
4
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease.用于治疗炎症性肺病的肝素、低分子量肝素及非抗凝衍生物
Pharmaceuticals (Basel). 2023 Apr 13;16(4):584. doi: 10.3390/ph16040584.
5
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?从细胞因子风暴到细胞因子微风：免疫发病机制的经验教训是否改善了中重度新冠肺炎的免疫调节治疗？
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
6
Role of Combined CT Pulmonary Angiography and Indirect CT Venography in Diagnosing Venous Thromboembolism in COVID-19 Patients - Experience From an Indian Quaternary Centre.联合 CT 肺动脉造影和间接 CT 静脉造影在 COVID-19 患者静脉血栓栓塞症诊断中的作用——来自印度四级中心的经验。
Vasc Endovascular Surg. 2023 Feb;57(2):129-136. doi: 10.1177/15385744221131424. Epub 2022 Sep 30.
7
Estimating incidence of venous thromboembolism in COVID-19: Methodological considerations.估算新型冠状病毒肺炎患者静脉血栓栓塞症的发病率：方法学考量
Res Pract Thromb Haemost. 2022 Aug 15;6(6):e12776. doi: 10.1002/rth2.12776. eCollection 2022 Aug.
8
Pulmonary thromboembolic events in COVID-19-A systematic literature review.新型冠状病毒肺炎中的肺血栓栓塞事件——一项系统文献综述
Pulm Circ. 2022 Jul 1;12(3):e12113. doi: 10.1002/pul2.12113. eCollection 2022 Jul.
9
Management of acute aortoiliac arterial thrombosis in patients with the novel coronavirus disease 2019: A case series and systematic review of the literature.2019年新型冠状病毒病患者急性主-髂动脉血栓形成的管理：病例系列及文献系统评价
Ann Vasc Surg Brief Rep Innov. 2022 Sep;2(3):100105. doi: 10.1016/j.avsurg.2022.100105. Epub 2022 Jul 6.
10
Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies.COVID-19 患者静脉血栓栓塞症的预测因素和死亡风险：观察性研究的系统评价和荟萃分析。
Ther Adv Cardiovasc Dis. 2022 Jan-Dec;16:17539447221105013. doi: 10.1177/17539447221105013.
本文引用的文献
1
Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom.英国一家教学医院收治的新冠肺炎重症监护患者的血栓形成并发症。
Thromb Res. 2020 Jul;191:76-77. doi: 10.1016/j.thromres.2020.04.028. Epub 2020 Apr 25.
2
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
3
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
4
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
5
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
6
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
7
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.非手术患者抗止血药品临床研究中严重出血的定义。
J Thromb Haemost. 2005 Apr;3(4):692-4. doi: 10.1111/j.1538-7836.2005.01204.x.
Zotero 插件